|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.21 CNY | +1.07% |
|
-5.27% | -28.91% |
Shanghai Serum Bio-Technology Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 190.2 million compared to CNY 174.22 million a year ago. Net income was CNY 40.67 million compared to CNY 64.14 million a year ago.
Basic earnings per share from continuing operations was CNY 0.38 compared to CNY 0.63 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -28.91% | 210M | |
| -1.59% | 89.49B | |
| +2.24% | 40.67B | |
| -12.97% | 33.15B | |
| +61.72% | 26.45B | |
| -20.71% | 14.69B | |
| -7.31% | 12.89B | |
| -12.64% | 11.54B | |
| -42.60% | 11.34B | |
| +4.27% | 8.84B |
SHANGHAI SERUM BIO-TECHNOLOGY CO., LTD. 
